High Functional P-glycoprotein Activity is More Often Present in T-cell Acute Lymphoblastic Leukaemic Cells in Adults than in Children
暂无分享,去创建一个
W. Kamps | A. Veerman | E. D. de Vries | E. Vellenga | W. Sluiter | S. Daenen | E. D. de Bont | S. Plasschaert | D. M. van der Kolk
[1] A. Berg,et al. Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984–1991 , 2000, Leukemia.
[2] D. Hoelzer,et al. Recent approaches in acute lymphoblastic leukemia in adults. , 2000, Reviews in clinical and experimental hematology.
[3] R. Pieters,et al. In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia , 2000, British journal of haematology.
[4] E. D. de Vries,et al. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[5] F. Baas,et al. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[6] O. Legrand,et al. Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia. , 1999, Blood.
[7] D. Keppler,et al. Export pumps for anionic conjugates encoded by MRP genes. , 1999, Advances in enzyme regulation.
[8] G. Peters,et al. MRP3, an organic anion transporter able to transport anti-cancer drugs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[9] J. Philippé,et al. P‐glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6‐year prospective study , 1999, British journal of haematology.
[10] P. Jansen,et al. ATP‐ and glutathione‐dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1 , 1999, British journal of pharmacology.
[11] S. Cole,et al. Multidrug resistance mediated by the ATP‐binding cassette transporter protein MRP , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.
[12] E. van den Berg,et al. Activity and expression of the multidrug resistance proteins MRP1 and MRP2 in acute myeloid leukemia cells, tumor cell lines, and normal hematopoietic CD34+ peripheral blood cells. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] O. Legrand,et al. Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. , 1998, Blood.
[14] H. Prentice,et al. The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties , 1998, Leukemia.
[15] R. Pieters,et al. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia. , 1998, Blood.
[16] E. Vellenga,et al. Improved outcome of adult acute lymphoblastic leukaemia by moderately intensified chemotherapy which includes a ‘pre‐induction’ course for rapid tumour reduction: preliminary results on 66 patients , 1998, British journal of haematology.
[17] M. Kool,et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. , 1997, Cancer research.
[18] J. Perentesis. Why is age such an important independent prognostic factor in acute lymphoblastic leukemia? , 1997, Leukemia.
[19] G. Reaman,et al. Correlation of P-glycoprotein expression and function in childhood acute leukemia: a children's cancer group study. , 1996, Blood.
[20] P. Sonneveld,et al. Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity. , 1996, Blood.
[21] E. Wattel,et al. Expression of the multidrug resistance P glycoprotein in newly diagnosed adult acute lymphoblastic leukemia: absence of correlation with response to treatment. , 1995, Leukemia.
[22] S. Proctor,et al. Corticosteroid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia , 1995, British journal of haematology.
[23] D. Keppler,et al. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. , 1994, The Journal of biological chemistry.
[24] P. Sonneveld,et al. Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells. , 1993, Blood.
[25] O. Fardel,et al. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. , 1993, Blood.
[26] A. Duncan,et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.
[27] C. Jasmin,et al. Concepts of remission, curability and lineage involvement in relationship to the problems of minimal residual leukaemia. , 1991, Bailliere's clinical haematology.
[28] B. Dörken,et al. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia. , 2000, Haematologica.
[29] R. Page,et al. Modulation of P-glycoprotein-mediated doxorubicin resistance in canine cell lines. , 2000, Anticancer research.
[30] J. Philippé,et al. Discordance of P-glycoprotein expression and function in acute leukemia. , 1999, Advances in experimental medicine and biology.
[31] P. Musto,et al. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression. , 1997, Haematologica.
[33] A. Ford-hutchinson,et al. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. , 1989, Canadian journal of physiology and pharmacology.